Loading…
Lunai Bioworks Inc. is projected to rise to $3.99 by 2027, a +36% move from its current price of $2.94. LNAI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $2.72 | $2.94 | $3.18 | 0.00% |
| Jul 13 | $2.63 | $2.94 | $3.28 | +0.01% |
| Jul 14 | $2.57 | $2.94 | $3.37 | +0.01% |
| Jul 15 | $2.52 | $2.94 | $3.44 | +0.02% |
| Jul 16 | $2.47 | $2.94 | $3.50 | +0.02% |
| Jul 17 | $2.43 | $2.94 | $3.56 | +0.03% |
| Jul 18 | $2.39 | $2.94 | $3.61 | +0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.39 | $2.94 | $3.61 | +0.03% |
| Week 2 | $2.20 | $2.94 | $3.94 | +0.06% |
| Week 3 | $2.06 | $2.94 | $4.21 | +0.09% |
| Week 4 | $1.95 | $2.94 | $4.45 | +0.12% |
| Week 5 | $1.86 | $2.94 | $4.67 | +0.15% |
| Week 6 | $1.78 | $2.95 | $4.88 | +0.18% |
| Week 7 | $1.71 | $2.95 | $5.09 | +0.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lunai Bioworks Inc. is a healthcare company described as a pre-clinical stage biotechnology firm that provides medicine, diagnostics, and biodefense products in the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC, and is developing a genetically modified allogeneic dendritic cell therapeutic vaccine portfolio, including RENB-DC11 for solid tumors (primarily pancreatic tumors) and RENB-DC20 for breast cancer.
The company is also advancing an artificial intelligence platform technology for early cancer detection and recurrence using a multi-omics approach to search for biomarkers that are present even in asymptomatic patients. Lunai Bioworks Inc. was formerly known as Renovaro Inc.
and changed its name to Lunai Bioworks Inc. in August 2025. It is headquartered in Los Angeles, California.
Lunai Bioworks Inc. (LNAI) currently trades at $2.82 per share with a market capitalization of $12.79M and a rank of 5071. The stock sits in a space where near-term movements reflect a neutral stance, with the 30-day trading range spanning from $1.63 to $4.89.
A major floor 61.7% below — a decisive break under it would weaken the trend.
The nearest floor, 23.1% below — buyers have tended to step in here.
The nearest ceiling, 46.3% above — a clean break opens room to run.
A major ceiling 77.1% above — clearing it would confirm fresh momentum.
Key LNAI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LNAI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.86 | Buy | $2.90 | Buy |
| MA 10 | $3.03 | Sell | $3.01 | Sell |
| MA 20 | $3.19 | Sell | $3.04 | Sell |
| MA 50 | $2.77 | Buy | $3.00 | Sell |
| MA 100 | $2.88 | Buy | $3.86 | Sell |
| MA 200 | $5.67 | Sell | $9.25 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.69 | Neutral |
| Stoch RSI (14) | 15.06 | Buy |
| CCI (20) | -40.33 | Neutral |
| Williams %R (14) | -86.62 | Info |
| MACD (12,26,9) | -0.09 | Sell |
| ROC (12) | -31.63 | Sell |
| Bollinger %B (20,2) | 0.38 | Neutral |
| Stochastic %K (14) | 13.38 | Buy |
| TRIX (15) | 0.66 | Buy |
| Awesome (5,34) | -0.09 | Sell |
| Ultimate (7,14,28) | 36.09 | Neutral |
| Momentum (10) | -0.62 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 2.70 | Buy |
| ADX (14) | 11.63 | Neutral |
| ATR (14) | 0.20 | Info |
The near-term picture shows neutral sentiment with a 14-day RSI of 50. The 50-day simple moving average sits at $2.76, while the 200-day simple moving average stands at $5.84. Key near-term levels include support at $2.11 and resistance at $4.30, framing a 30-day range of $1.63 to $4.89.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.47 | $2.94 | $4.52 | 0% | Neutral | |
| $2.89 | $3.99 | $5.94 | +36% | Bullish | |
| $3.00 | $4.40 | $6.99 | +50% | Bullish | |
| $2.81 | $4.34 | $7.23 | +48% | Bullish | |
| $2.34 | $3.79 | $6.57 | +29% | Bullish | |
| $2.28 | $3.85 | $6.91 | +31% | Bullish | |
| $1.95 | $3.45 | $6.38 | +17% | Neutral | |
| $2.29 | $4.21 | $8.02 | +43% | Bullish | |
| $3.17 | $6.07 | $11.84 | +106% | Bullish | |
| $2.71 | $5.37 | $10.73 | +83% | Bullish | |
| $3.30 | $7.34 | $16.11 | +150% | Bullish | |
| $4.21 | $9.36 | $21.53 | +218% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.47 | $2.94 | $3.78 | +0.00% |
| August 2026 | $2.50 | $3.03 | $3.82 | +2.90% |
| September 2026 | $2.40 | $2.95 | $3.80 | -2.45% |
| October 2026 | $2.61 | $3.25 | $4.26 | +10.15% |
| November 2026 | $2.77 | $3.48 | $4.63 | +7.10% |
| December 2026 | $2.64 | $3.35 | $4.52 | -3.67% |
Click any year to see its month-by-month LNAI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, LNAI is projected to trade between $1.47 and $4.52, averaging $2.94 — a potential gain of 0% from today's $2.94. A consolidation phase looks the most probable path here.
Lunai Bioworks Inc.'s 2027 outlook centres on $3.99, within a $2.89 to $5.94 range. That is up +36% on the projected 2026 average. That marks a +36% change versus current levels. Momentum favours further upside here.
By 2028, LNAI could reach as high as $6.99, with a base case around $4.40 and support toward $3.00 — roughly +50% from $2.94. Buyers look set to stay in control over this stretch.
Expect LNAI to range from $2.81 to $7.23 through 2029. The $4.34 average target implies a +48% move from current prices. That is -1% versus the projected 2028 average. Momentum favours further upside here.
The LNAI price prediction for 2030 points to an average of $3.79 (low $2.34, high $6.57) — a potential gain of +29% on today's $2.94. Buyers look set to stay in control over this stretch.
In 2031, LNAI is projected to trade between $2.28 and $6.91, averaging $3.85 — a potential gain of +31% from today's $2.94. That is up +2% on the projected 2030 average. Momentum favours further upside here.
Lunai Bioworks Inc.'s 2032 outlook centres on $3.45, within a $1.95 to $6.38 range. That is -10% versus the projected 2031 average. That marks a +17% change versus current levels. A consolidation phase looks the most probable path here.
By 2033, LNAI could reach as high as $8.02, with a base case around $4.21 and support toward $2.29 — roughly +43% from $2.94. Momentum favours further upside here.
Expect LNAI to range from $3.17 to $11.84 through 2034. The $6.07 average target implies a +106% move from current prices. That is up +44% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The LNAI price prediction for 2035 points to an average of $5.37 (low $2.71, high $10.73) — a potential gain of +83% on today's $2.94. Momentum favours further upside here.
In 2040, LNAI is projected to trade between $3.30 and $16.11, averaging $7.34 — a potential gain of +150% from today's $2.94. That is up +37% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Lunai Bioworks Inc.'s 2050 outlook centres on $9.36, within a $4.21 to $21.53 range. That is up +28% on the projected 2040 average. That marks a +218% change versus current levels. Momentum favours further upside here.
Investing $1,000 in LNAI today (≈ 340.136054 LNAI) could be worth
$3,184.27
+$2,184.27 (+218%) by 2050 · US Dollar
Based on the average projected LNAI price of $9.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LNAIwould be worth at today's price.
$1,000 invested in LNAI on Jul 10, 2025 (≈ 42.059221 LNAI) would be worth
$123.65
-$876.35 (-87.6%) today · 0.12× · US Dollar
Based on a LNAI entry price of $23.78 vs. today's $2.94.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.2 | $918.75 | -8.1% |
| 1 month ago | $2.26 | $1,300.88 | +30.1% |
| 3 months ago | $2.97 | $990.83 | -0.9% |
| 6 months ago | $7.55 | $389.59 | -61.0% |
| 1 year ago | $23.78 | $123.65 | -87.6% |
| All time (5.0y) ago | $408 | $7.21 | -99.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LNAI forecast.
Our base-case forecast reaches $5.90 around 2034.
Implied market cap at $5.90: $26.75M
The multi-year forecast depicts a bullish trajectory in most years beyond 2026, with the average price rising from $2.82 in 2026 to higher levels in later years. Notably, 2027 shows an average of $3.85 with a 36.6% ROI, and 2028 at $4.21 with a 49.3% ROI, followed by 2029 at $4.15 (47.2% ROI). The 2030 forecast presents an average of $3.66 with a 29.9% ROI, and 2031 at $3.67 (30.2% ROI).
The outlook strengthens into 2034 with an average of $5.82 (106.3% ROI) and 2035 at $5.13 (81.9% ROI). By 2040, the average reaches $7.05 with a 149.9% ROI, and by 2050 the average is $8.94 with a 217.1% ROI, all while sentiment remains bullish. These figures illustrate potential upside alongside periods of lower returns, and they are estimates rather than guarantees.
Tap a question to reveal the answer.
2030 forecast shows a min of $2.26, an average of $3.66, and a max of $6.36 with a 29.9% ROI and bullish sentiment.
The forecast indicates bullish sentiment in multiple years (notably 2027 onward) with rising average prices (e.g., 2027 avg $3.85, 2028 avg $4.21, 2034 avg $5.82) and positive ROI in several years, though 2026 is Neutral and outcomes are not guaranteed.
Yes. The 2034 max is $11.36 and the 2040 max is $15.47, with the 2050 max at $20.57, indicating potential to exceed $10 in several later years.
The current price is $2.82 and the market capitalization is $12.79M.
Near-term indicators show Neutral sentiment with RSI 14 at 50, SMA50 at $2.76, and SMA200 at $5.84. The stock has support at $2.11 and resistance at $4.30, with a 30-day trading range of $1.63 to $4.89.
Lunai Bioworks Inc. Community Discussion
0Share your Lunai Bioworks Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.